Lowering the prophylactic platelet transfusion threshold: A prospective analysis

被引:48
|
作者
Lawrence, JB [1 ]
Yomtovian, RA [1 ]
Hammons, T [1 ]
Masarik, SR [1 ]
Chongkolwatana, V [1 ]
Creger, RJ [1 ]
Manka, A [1 ]
Lazarus, HM [1 ]
机构
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
关键词
platelet transfusion; hemorrhage; thrombocytopenia; leukemia; blood & marrow transplant;
D O I
10.3109/10428190109057955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The 20 x 10(9)/L threshold for prophylactic platelet transfusion may be unnecessarily high. Few prospective studies. however, in which other trigger values were tested have been published. In this study all hospitalized, thrombocytopenic adult hematology-oncology patients in our institution were prospectively evaluated daily for hemorrhage and platelet transfusion during a one year period; no patients were excluded for bleeding or infectious problems. By design, during the initial six-months: (baseline period), the prophylactic platelet transfusion trigger was 20 x 10(9)/L; for the second six-months (study period) this threshold was changed to 10 x 10(9)/L. Patients studied during the two periods did not differ significantly in age, gender. diagnosis. blood or marrow transplant status, and duration of neutropenia. Compliance with the thresholds was 95.6% (baseline period) and 93.5% (study period). For patients with platelet counts under 20 x 10(9)/L. the mean use of platelet transfusions per patient per day was significantly lower in the study period (4.47) than in the baseline period (6.48: p<0.001). Both mean prophylactic (1.54/patient-day) and therapeutic (2.93/patient-day) platelet transfusions were reduced in the study period compared with the baseline period (2.16 and 4.22/patient-day, respectively). Hemorrhage was slightly reduced in the study period compared with the baseline period: major hemorrhage, 15.2% vs. 18.4% (p=0.014): minor hemorrhage. 63.6% vs. 70.1% (p<0.001). Thus, hemorrhage was not increased with the lower trigger level. A 10 x 10(9)/L prophylactic platelet transfusion threshold value is safe and effective.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 50 条
  • [31] Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies
    Wu, Yi-Feng
    Shen, Chih-Lung
    Huang, Wei-Han
    Chu, Sung-Chao
    Li, Chi-Cheng
    Liu, Chao-Zong
    Wang, Tso-Fu
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (04) : 722 - 730
  • [32] PROPHYLACTIC PLATELET ADMINISTRATION DURING MASSIVE TRANSFUSION - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND CLINICAL-STUDY
    REED, RL
    CIAVARELLA, D
    HEIMBACH, DM
    BARON, L
    PAVLIN, E
    COUNTS, RB
    CARRICO, CJ
    ANNALS OF SURGERY, 1986, 203 (01) : 40 - 48
  • [33] CONTROVERSIES IN TRANSFUSION MEDICINE - PROPHYLACTIC PLATELET TRANSFUSION REVISITED AFTER 25 YEARS - CON
    PATTEN, E
    TRANSFUSION, 1992, 32 (04) : 381 - 385
  • [34] New strategies for prophylactic platelet transfusion in patients with hematologic diseases
    Wandt, H
    Ehninger, G
    Gallmeier, WM
    ONCOLOGIST, 2001, 6 (05): : 446 - 450
  • [35] Prophylactic platelet transfusion in children with thrombocytopenic disorders: A retrospective review
    Ferrara, M.
    Capozzi, L.
    Coppola, A.
    Save, G.
    Coppola, L.
    HEMATOLOGY, 2007, 12 (04) : 297 - 299
  • [36] The platelet prophylactic transfusion trigger: when expectations meet reality
    Brecher, Mark E.
    TRANSFUSION, 2007, 47 (02) : 188 - 191
  • [37] Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients
    Lee, Tau-Hong
    Wong, Joshua G. X.
    Leo, Yee-Sin
    Thein, Tun-Linn
    Ng, Ee-Ling
    Lee, Linda K.
    Lye, David C.
    PLOS NEGLECTED TROPICAL DISEASES, 2016, 10 (03):
  • [38] What is the Threshold for initiating Platelet Transfusion in Premature Babies?
    Lichert, Frank
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2019, 223 (01): : 10 - +
  • [39] Platelet transfusion: Products, indications, dose, threshold and efficacy
    Andreu, G.
    Vasse, J.
    Tardivel, R.
    Semana, G.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2009, 16 (02) : 118 - 133
  • [40] Risk Factors for Bleeding: A Modelling Analysis of the TOPPS Randomized Controlled Trial of Prophylactic Platelet Transfusion
    Wood, Erica M.
    Hudson, Cara
    Estcourt, Lise
    Johnson, Rachel
    Stanworth, Simon J.
    BLOOD, 2014, 124 (21)